Related references
Note: Only part of the references are listed.Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression
Arun Sreekumar et al.
NATURE (2009)
Glycine N-methyltransferase affects the metabolism of aflatoxin B1 and blocks its carcinogenic effect
Chia-Hung Yen et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2009)
D-Serine and a glycine transporter inhibitor improve MK-801-induced cognitive deficits in a novel object recognition test in rats
Jun-Ichi Karasawa et al.
BEHAVIOURAL BRAIN RESEARCH (2008)
Sarcosine (N-Methylglycine) treatment for acute schizophrenia: A randomized, double-blind study
Hsien-Yuan Lane et al.
BIOLOGICAL PSYCHIATRY (2008)
Glycine transport inhibitors and the treatment of schizophrenia
Daniel C. Javitt
BIOLOGICAL PSYCHIATRY (2008)
Loss of the glycine N-methyltransferase gene leads to steatosis and hepatocellular carcinoma in mice
M. Luz Martinez-Chantar et al.
HEPATOLOGY (2008)
The Cognitive and Negative Symptoms in Schizophrenia, Trial (CONSIST): The efficacy of glutamatergic agents for negative symptoms and cognitive impairments
Robert W. Buchanan et al.
AMERICAN JOURNAL OF PSYCHIATRY (2007)
Glycine transporter I inhibitor, N-methylglycine (Sarcosine), added to clozapine for the treatment of schizophrenia
Hsien-Yuan Lane et al.
BIOLOGICAL PSYCHIATRY (2006)
D-alanine added to antipsychotics for the treatment of schizophrenia
GE Tsai et al.
BIOLOGICAL PSYCHIATRY (2006)
Sarcosine or D-serine add-on treatment for acute exacerbation of schizophrenia - A randomized, double-blind, placebo-controlled study
HY Lane et al.
ARCHIVES OF GENERAL PSYCHIATRY (2005)
A six-month, placebo-controlled trial of D-cycloserine co-administered with conventional antipsychotics in schizophrenia patients
DC Goff et al.
PSYCHOPHARMACOLOGY (2005)
D-serine efficacy as add-on pharmacotherapy to risperidone and olanzapine for treatment-refractory schizophrenia
U Heresco-Levy et al.
BIOLOGICAL PSYCHIATRY (2005)
Fine-tuning risperidone dosage for acutely exacerbated schizophrenia: clinical determinants
HY Lane et al.
PSYCHOPHARMACOLOGY (2004)
Glycine transporter I inhibitor, N-methylglycine (Sarcosine), added to antipsychotics for the treatment of schizophrenia
GC Tsai et al.
BIOLOGICAL PSYCHIATRY (2004)
Reversal of phencyclidine-induced dopaminergic dysregulation by N-methyl-D-aspartate receptor/glycine-site agonists
DC Javitt et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Comparative effects of glycine and D-cycloserine on persistent negative symptoms in schizophrenia: a retrospective analysis
U Heresco-Levy et al.
SCHIZOPHRENIA RESEARCH (2004)
High-dose glycine added to olanzapine and risperidone for the treatment of schizophrenia
U Heresco-Levy et al.
BIOLOGICAL PSYCHIATRY (2004)
D-Serine-induced nephrotoxicity: possible interaction with tyrosine metabolism
RE Williams et al.
TOXICOLOGY (2004)
Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria
MF Green et al.
BIOLOGICAL PSYCHIATRY (2004)
Gene knockout of glycine transporter 1: Characterization of the behavioral phenotype
G Tsai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Inactivation of the glycine transporter 1 gene discloses vital role of glial glycine uptake in Glycinergic inhibition
J Gomeza et al.
NEURON (2003)
Glycine tranporter-1 blockade potentiates NMDA-mediated responses in rat prefrontal cortical neurons in vitro and in vivo
L Chen et al.
JOURNAL OF NEUROPHYSIOLOGY (2003)
Are tryptophan and 5-hydroxytryptophan effective treatments for depression? A meta-analysis
K Shaw et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2002)
Placebo-controlled trial of D-cycloserine added to conventional neuroleptics, olanzapine, or risperidone in schizophrenia
U Heresco-Levy et al.
AMERICAN JOURNAL OF PSYCHIATRY (2002)
Pharmacological assessment of the role of the glycine transporter GlyT-1 in mediating high-affinity glycine uptake by rat cerebral cortex and cerebellum synaptosomes
HJ Herdon et al.
NEUROPHARMACOLOGY (2001)
Risperidone in acutely exacerbated schizophrenia: Dosing strategies and plasma levels
HY Lane et al.
JOURNAL OF CLINICAL PSYCHIATRY (2000)
Share Paper
